位于密码子 249 处的 P53 基因突变在新生儿科特布病胆道闭锁中并不常见

M. Kotb, Ayda Kelany, Sherif Shehata, Gamal H. El Tagy, S. Kaddah, Haytham Esmat, Nahla Sabry, Ahmed Elhaddad, Radwa A. Shamma
{"title":"位于密码子 249 处的 P53 基因突变在新生儿科特布病胆道闭锁中并不常见","authors":"M. Kotb, Ayda Kelany, Sherif Shehata, Gamal H. El Tagy, S. Kaddah, Haytham Esmat, Nahla Sabry, Ahmed Elhaddad, Radwa A. Shamma","doi":"10.21608/cupsj.2023.231747.1102","DOIUrl":null,"url":null,"abstract":": Background: Hepatocellular carcinoma (HCC) is known to result from aflatoxin B1 that induces p53 mutation at codon 249. Aflatoxins are also known to cause The Kotb disease Biliary atresia (BA) variant which is characterized by congenital aflatoxicosis B1 in neonates with null glutathione S transferase M1. Aim of the Work: We aimed to search for the aflatoxin B1 induced HCC 249 codon p53 mutation among neonates with Kotb disease BA variant and their mothers. Patients and Methods: This study included 13 neonates and infants with confirmed BA who presented to Hepatology Clinic, New Children Hospital, Cairo University, Egypt during January-May 2019. All subjects and their mothers underwent detection of aflatoxins from peripheral blood. BA cases underwent detection of mutation from liver biopsy tissue as well. Results: The studied cohort with confirmed BA comprised 9 (69.2%) girls and 4 (30.8%) boys, with mean ages ± standard deviation (SD) at onset, presentation, diagnosis and portoenterostomy of 8.1±5.7 days, 44.8±11 days, 57±14.53 and 64.5±21.34 days respectively. All 13 and their mothers were found to have elevated blood levels of aflatoxin B1 with a mean of 8.56 ± 4.2ng/ml and 14.75±16.78ng/ml respectively. The mean ± SD duration of follow up was 259.1±141 days. None of the mothers had abnormal levels of bilirubin or liver aminotransferases. All samples tested negative for p53 mutation at codon 249 except for one infant who tested negative for the mutation in his whole blood and had heterozygous mutation in DNA from his liver tissue. None of the studied cohort or their mothers had HCC. Cholestasis resolved in 2 children, 7 had progressive course and 4 died. There was no correlation between outcome and neonate/maternal aflatoxin B1 level (p=0.299; p=0.443), age at portoenterostomy (p=0.93), hepatic fibrosis degree (p=0.56), or other lab or liver biopsy findings. Conclusion: p53 mutation at codon 249 is uncommon in infants with Kotb disease BA variant, despite the aflatoxicosis they suffer from. The cause remains to be studied. Screening for p53 mutation at codon 249 cannot be used as a diagnostic test for Kotb disease.","PeriodicalId":153483,"journal":{"name":"Pediatric Sciences Journal","volume":"66 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"P53 Mutation at Codon 249 is Uncommon in Neonatal Kotb Disease Biliary Atresia\",\"authors\":\"M. Kotb, Ayda Kelany, Sherif Shehata, Gamal H. El Tagy, S. Kaddah, Haytham Esmat, Nahla Sabry, Ahmed Elhaddad, Radwa A. Shamma\",\"doi\":\"10.21608/cupsj.2023.231747.1102\",\"DOIUrl\":null,\"url\":null,\"abstract\":\": Background: Hepatocellular carcinoma (HCC) is known to result from aflatoxin B1 that induces p53 mutation at codon 249. Aflatoxins are also known to cause The Kotb disease Biliary atresia (BA) variant which is characterized by congenital aflatoxicosis B1 in neonates with null glutathione S transferase M1. Aim of the Work: We aimed to search for the aflatoxin B1 induced HCC 249 codon p53 mutation among neonates with Kotb disease BA variant and their mothers. Patients and Methods: This study included 13 neonates and infants with confirmed BA who presented to Hepatology Clinic, New Children Hospital, Cairo University, Egypt during January-May 2019. All subjects and their mothers underwent detection of aflatoxins from peripheral blood. BA cases underwent detection of mutation from liver biopsy tissue as well. Results: The studied cohort with confirmed BA comprised 9 (69.2%) girls and 4 (30.8%) boys, with mean ages ± standard deviation (SD) at onset, presentation, diagnosis and portoenterostomy of 8.1±5.7 days, 44.8±11 days, 57±14.53 and 64.5±21.34 days respectively. All 13 and their mothers were found to have elevated blood levels of aflatoxin B1 with a mean of 8.56 ± 4.2ng/ml and 14.75±16.78ng/ml respectively. The mean ± SD duration of follow up was 259.1±141 days. None of the mothers had abnormal levels of bilirubin or liver aminotransferases. All samples tested negative for p53 mutation at codon 249 except for one infant who tested negative for the mutation in his whole blood and had heterozygous mutation in DNA from his liver tissue. None of the studied cohort or their mothers had HCC. Cholestasis resolved in 2 children, 7 had progressive course and 4 died. There was no correlation between outcome and neonate/maternal aflatoxin B1 level (p=0.299; p=0.443), age at portoenterostomy (p=0.93), hepatic fibrosis degree (p=0.56), or other lab or liver biopsy findings. Conclusion: p53 mutation at codon 249 is uncommon in infants with Kotb disease BA variant, despite the aflatoxicosis they suffer from. The cause remains to be studied. Screening for p53 mutation at codon 249 cannot be used as a diagnostic test for Kotb disease.\",\"PeriodicalId\":153483,\"journal\":{\"name\":\"Pediatric Sciences Journal\",\"volume\":\"66 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-12-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Sciences Journal\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.21608/cupsj.2023.231747.1102\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Sciences Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.21608/cupsj.2023.231747.1102","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

:背景:已知肝细胞癌(HCC)是由黄曲霉毒素 B1 导致 p53 密码子 249 突变引起的。黄曲霉毒素还可导致 Kotb 病胆道闭锁(BA)变异型,其特点是新生儿先天性黄曲霉毒素中毒 B1,且谷胱甘肽 S 转移酶 M1 为空。工作目的我们的目的是在患有 Kotb 病 BA 变异型的新生儿及其母亲中寻找黄曲霉毒素 B1 诱导的 HCC 249 密码子 p53 突变。患者和方法:本研究纳入了2019年1月至5月期间在埃及开罗大学新儿童医院肝病门诊就诊的13名确诊为BA的新生儿和婴儿。所有受试者及其母亲均接受了外周血黄曲霉毒素检测。BA 病例还接受了肝脏活检组织的突变检测。研究结果所研究的确诊 BA 组群包括 9 名(69.2%)女孩和 4 名(30.8%)男孩,发病、就诊、确诊和门静脉造口术时的平均年龄(± 标准差 (SD))分别为 8.1±5.7天、44.8±11天、57±14.53 天和 64.5±21.34天。所有 13 名儿童及其母亲的血液中黄曲霉毒素 B1 含量均升高,平均值分别为 8.56±4.2ng/ml 和 14.75±16.78ng/ml。平均(± SD)随访时间为 259.1±141 天。没有一位母亲的胆红素或肝脏转氨酶水平出现异常。除了一名婴儿的全血p53密码子249突变检测呈阴性,但其肝组织DNA中存在杂合突变外,其他所有样本均呈阴性。研究组中没有人或其母亲患有 HCC。2名患儿的胆汁淤积得到缓解,7名患儿的胆汁淤积呈进行性发展,4名患儿死亡。研究结果与新生儿/母亲黄曲霉毒素 B1 水平(P=0.299;P=0.443)、肠造口年龄(P=0.93)、肝纤维化程度(P=0.56)、其他实验室或肝活检结果均无相关性。结论:尽管患有黄曲霉毒素中毒,但在患有 Kotb 病 BA 变异型的婴儿中,密码子 249 的 p53 突变并不常见。病因仍有待研究。筛查p53 249密码子突变不能作为Kotb病的诊断测试。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
P53 Mutation at Codon 249 is Uncommon in Neonatal Kotb Disease Biliary Atresia
: Background: Hepatocellular carcinoma (HCC) is known to result from aflatoxin B1 that induces p53 mutation at codon 249. Aflatoxins are also known to cause The Kotb disease Biliary atresia (BA) variant which is characterized by congenital aflatoxicosis B1 in neonates with null glutathione S transferase M1. Aim of the Work: We aimed to search for the aflatoxin B1 induced HCC 249 codon p53 mutation among neonates with Kotb disease BA variant and their mothers. Patients and Methods: This study included 13 neonates and infants with confirmed BA who presented to Hepatology Clinic, New Children Hospital, Cairo University, Egypt during January-May 2019. All subjects and their mothers underwent detection of aflatoxins from peripheral blood. BA cases underwent detection of mutation from liver biopsy tissue as well. Results: The studied cohort with confirmed BA comprised 9 (69.2%) girls and 4 (30.8%) boys, with mean ages ± standard deviation (SD) at onset, presentation, diagnosis and portoenterostomy of 8.1±5.7 days, 44.8±11 days, 57±14.53 and 64.5±21.34 days respectively. All 13 and their mothers were found to have elevated blood levels of aflatoxin B1 with a mean of 8.56 ± 4.2ng/ml and 14.75±16.78ng/ml respectively. The mean ± SD duration of follow up was 259.1±141 days. None of the mothers had abnormal levels of bilirubin or liver aminotransferases. All samples tested negative for p53 mutation at codon 249 except for one infant who tested negative for the mutation in his whole blood and had heterozygous mutation in DNA from his liver tissue. None of the studied cohort or their mothers had HCC. Cholestasis resolved in 2 children, 7 had progressive course and 4 died. There was no correlation between outcome and neonate/maternal aflatoxin B1 level (p=0.299; p=0.443), age at portoenterostomy (p=0.93), hepatic fibrosis degree (p=0.56), or other lab or liver biopsy findings. Conclusion: p53 mutation at codon 249 is uncommon in infants with Kotb disease BA variant, despite the aflatoxicosis they suffer from. The cause remains to be studied. Screening for p53 mutation at codon 249 cannot be used as a diagnostic test for Kotb disease.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信